Abstract TMP91: Prediction of Recurrent Embolism and Major Hemorrhage in Patients With Acute Stroke and Atrial Fibrillation by Risk Stratification Schema The Alessa Score Study


    loading  Checking for direct PDF access through Ovid

Abstract

Background: We aim to derive and validate a score that predicts early ischemic events or major hemorrhage in acute stroke patients with atrial fibrillation (AF).Methods and results: The derivation cohort consisted of 854 patients with acute ischemic stroke and AF (mean age 76.3 y, 46.6% M) included between January 2012 and March 2014. Older age (HR 1.06 for each additional year, p=0.0025) and severe atrial enlargement (HR 2.05, p= 0.027) resulted being predictors for recurrent ischemic event (stroke, TIA, systemic embolism) within 90 days from acute stroke. Small infarct size (≤1.5 cm) was inversely correlated with both severe bleeding (HR 0.39, p=0.03) and recurrent ischemic events (HR 0.44, p=0.01). Considering the magnitude of the effect, we assigned 2 points to age ≥80 y; 1 point to 70-79 y; 1 point to presence of ischemic index lesion >1.5 cm; 1 point to severe atrial enlargement (ALESSA score). An increase in this score was associated with recurrent ischemic event but not major hemorrhage. A logistic regression with the ROC graph procedure (C-statistic) showed an area under the curve of 0.697 (0.632-0.763), p=0.0001 for ischemic outcome event and 0.585 (0.493-0.678), p=0.47 for major hemorrhage. On multivariate analysis, ALESSA >2 was associated with recurrent ischemic event (OR: 2.5, 95% CI 1.4-4.4, p=0.001) but not major hemorrhage (OR: 1.1, 95% CI 0.5-2.4, p=0.9). The validation cohort included 994 patients with acute stroke and AF (mean age 75.8 y, 46.0% M) included between April 2014 and June 2016. Also in this cohort, a higher ALESSA score was associated with recurrent ischemic event but not major hemorrhage. Logistic regression with the ROC graph procedure showed an area under the curve of 0.646 (0.529-0.763), p=0.009 for recurrent ischemic event and 0.407 (0.275-0.540), p=0.14 for major hemorrhage. On multivariate analysis, ALESSA >2 barely lacked being significantly correlated with recurrent ischemic event (OR: 2.07, 95% CI 0.93-4.67, p=0.07).Conclusions: A higher ALESSA score is associated with a higher risk of recurrent ischemic event but not with major hemorrhage. Therefore, patients with acute stroke and AF and an ALESSA score >2 may be candidates for early anticoagulation treatment. Further validations of this schema need to be performed.

    loading  Loading Related Articles